site stats

Telara pharma sl

WebCompany type: Sociedad Limitada, Active: VAT Number (CIF) B02839470: Universal Entity Code: 8351-6250-1732-0076: Record last updated: Thursday, July 21, 2024 8:56:16 PM UTC WebApr 16, 2024 · Arch Biopartners Inc. has announced the signing of a licensing agreement with Telara Pharma SL for its patents relating to Cilastatin, dipeptidase-1 (DPEP-1) antagonists. The licensing deal which awards commercial rights for the patents, is put through mainly for Arch to use them in developing a treatment for acute kidney injury.

Genesis Biomed drives Telara Pharma, a spin-off from the …

WebPurdue Pharma and its subsidiaries are physician-founded and physician-led companies that develop, manufacture and market medications and consumer health products to meet the evolving needs of ... WebApr 14, 2024 · Clinical Specialist - SL Altamonte Springs, FL, USA * Florida, USA * Store 320, Altamonte Springs, Florida, United States of America Req #28843 … t4 free 1.0 ng/dl https://pineleric.com

Leanbio participates in a European project to boost nano …

WebScrip is part of Pharma Intelligence UK Limited. This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number … WebApr 15, 2024 · Telara Pharma is focused on the research, development, and marketing of drugs for the treatment of high prevalence pathologies (mainly kidney injuries and … WebMay 10, 2024 · Telara Pharma has signed an exclusive worldwide license agreement with the Canadian company Arch Biopartners to use cilastatin in the treatment and prevention of acute kidney injury and in sepsis processes. Cilastatin is a small molecule inhibitor of the dipeptidase-1 (DPEP-1) enzyme developed in the 1980s to prevent degradation of the … t4 free by eia

Mariángeles González Nicolás’ Post - LinkedIn

Category:Telara Pharma – Developing therapeutic solutions for the …

Tags:Telara pharma sl

Telara pharma sl

Telara Pharma Stock Price, Funding, Valuation, Revenue

WebAbout Telara Pharma has 2 current employee profiles, including Co-Founder Alberto Lázaro. Contacts We're working on getting contact data for Telara Pharma Find more contact data in Search! Get started Employee Profiles Number of Employee Profiles 2 Telara Pharma has 2 current employee profiles, including Co-Founder Alberto Lázaro. WebApr 15, 2024 · Arch Biopartners ( OTCQB:ACHFF) announces that it has entered into an exclusive worldwide license agreement with Telara Pharma of Spain to clinically develop and market cilastatin, a...

Telara pharma sl

Did you know?

WebTelara Pharma has designed a drug capable of preventing acute kidney injury. Headquarters Location Madrid, Spain Suggest an edit Missing: Telara Pharma 's Product Demo & Case Studies Promote your product offering to tech buyers. Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions. WebMay 14, 2024 · Business Description Telara Pharma S.L. is a spin-off company from the Gregorio Marañón Health Research Institute (IiSGM), Gregorio Marañón Universitary …

WebApr 15, 2024 · Arch Biopartners is a clinical stage company developing new drug candidates for treating organ damage caused by inflammation Novel Mechanism of Action - WebMay 10, 2024 · The company's drug is a small molecule inhibitor of the dipeptidase-1 (DPEP-1) enzyme to prevent degradation of the Imipenem antibiotic in the kidney, enabling …

WebSee Telara Pharma funding rounds, investors, investments, exits and more. Evaluate their financials based on Telara Pharma's post-money valuation and revenue. WebMay 10, 2024 · The company's drug is a small molecule inhibitor of the dipeptidase-1 (DPEP-1) enzyme to prevent degradation of the Imipenem antibiotic in the kidney, enabling doctors to prevent the patients from the toxicity of other drugs and generalized infections from causing kidney damage. Contact Information Website www.telarapharma.com …

WebUna spin-off para el proyecto Cilastatina, el primer nefroprotector del mundo descubierto por el fallecido Dr. Tejedor y su equipo

WebApr 15, 2024 · Arch Biopartners is a clinical stage company developing new drug candidates for treating organ damage caused by inflammationNovel Mechanism of Action - selective dipeptidase-1 antagonists that... March 8, 2024 t4 free measurementWebApr 15, 2024 · The patents held by Arch and Telara are now unified into one clinical development program to be led by Arch. These patents include method of use claims for the use of cilastatin as a potential... t4 free is lowWebApr 15, 2024 · Arch Biopartners Enters into Worldwide License Agreement with Telara Pharma to Re-Purpose Cilastatin for the Treatment and Prevention of Acute Kidney Injury. GlobeNewswire Apr 15, 2024 7:00 AM EDT. t4 free not indicated ng/dlWebTelara Pharma S.L. - BioCentury Company Profiles for the biopharma industry t4 free tube colorWebApr 15, 2024 · Arch Biopartners Inc. announced it has entered into an exclusive worldwide license agreement with Telara Pharma of Spain (“Telara”) to clinically develop and market cilastatin, a small-molecule drug candidate for […] t4 free is low and tsh is highWebApr 15, 2024 · AP NEWS . Listen. Sections t4 free levels in hypothyroidismt4 gloves and helmet